There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CA125


CA125 Molecule Information

Target Synonym:Mucin-16?CA125?Ovarian carcinoma antigen CA125?CA-125?MUC16?MUC-16?Ovarian cancer-related tumor marker CA125
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase ?

CA125 Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
CA5-H82F4 Human Biotinylated Human CA125 / MUC16 Protein, Fc Tag, Avi Tag (Avitag™)

CA125 Molecule Synonym Name

CA125, CA-125, CA125MUC-16, FLJ14303, MUC16, mucin 16, mucin-16

CA125 Molecule Background

The CA125, also known as the MUC16, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy. The CA 125 molecule is almost certainly a glycoprotein with a predominance of O-linkages. It is heterogeneous with regard to both size and charge, most likely due to continuous deglycosylation of side chains during its life-span in bodily fluids. It exists as a very large complex (perhaps as much as 4 million daltons) under natural conditions.

CA125 References

CA125 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
RG-7882 RG-7882; D-4064A; DMUC-4064A Phase Ⅰ Genentech Ovarian cancer, Pancreatic cancer Details
Oregovomab B43.13 Phase Ⅱ Paladin Pharma, National Cancer Institute, Quest PharmaTech, University of Nebraska Medical Center Ovarian cancer, Pancreatic cancer Details
Sofituzumab vedotin RG-7458; DMUC-5754A Phase Ⅰ Genentech Fallopian tube cancer, Peritoneum cancer, Ovarian cancer, Pancreatic cancer Details
JCAR-020 JCAR-020 Phase Ⅰ Memorial Sloan-Kettering Cancer Center, Juno Therapeutics Ovarian cancer Details

This web search service is supported by Google Inc.